3.239.11.178
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-

Endocrinology

Study finds limited incidence of glycemic excursions in patients with TED treated with teprotumumab

Serious glycemic excursions are uncommon in patients with thyroid eye disease (TED) who receive teprotumumab therapy, particularly in those who are normoglycemic before treatment, according to a new study. The study indicates that patients with controlled diabetes or impaired glucose tolerance can be safely treated with teprotumumab, as long as...

Read More
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement-